Cutler Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-195
Closed -$25K 4283
2023
Q1
$25K Buy
+195
New +$24.5K ﹤0.01% 1804
2022
Q4
Sell
-188
Closed -$19K 5372
2022
Q3
$19K Buy
+188
New +$20.6K ﹤0.01% 2670
2022
Q2
Sell
-8,300
Closed -$985K 5796
2022
Q1
$1.06M Buy
+8,300
New +$1M 0.06% 371
2020
Q4
Sell
-515
Closed -$72.7K 5611
2020
Q3
$68K Sell
515
-2,163
-81% -$283K ﹤0.01% 1578
2020
Q2
$310K Sell
2,678
-2,781
-51% -$320K 0.02% 656
2020
Q1
$535K Buy
+5,459
New +$716K 0.03% 534
2018
Q4
Sell
-4,429
Closed -$498K 4694
2018
Q3
$507K Buy
4,429
+1,442
+48% +$171K 0.04% 460
2018
Q2
$323K Sell
2,987
-103
-3% -$11.2K 0.03% 589
2018
Q1
$327K Sell
3,090
-14,384
-82% -$1.67M 0.03% 580
2017
Q4
$2.05M Sell
17,474
-22,224
-56% -$2.51M 0.08% 170
2017
Q3
$4.51M Buy
39,698
+29,408
+286% +$3.39M 0.17% 90
2017
Q2
$1.28M Buy
10,290
+942
+10% +$112K 0.05% 338
2017
Q1
$1.11M Sell
9,348
-3,911
-29% -$443K 0.05% 340
2016
Q4
$1.33M Buy
13,259
+13,156
+12,773% +$1.41M 0.05% 316
2016
Q3
$13K Sell
103
-593
-85% -$73.3K ﹤0.01% 3930
2016
Q2
$81K Buy
+696
New +$78.8K ﹤0.01% 1889
2016
Q1
Sell
-3,633
Closed -$351K 7332
2015
Q4
$361K Buy
+3,633
New +$355K 0.02% 795

Other funds holding ZBH

Cutler Group's ZBH Position: Q2 2023 in Review

Cutler Group sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 195 shares — an estimated $25K sold.

Cutler Group first reported a position in ZBH in Q4 2015 and held it in 17 quarters. The position peaked at $4.51M in Q3 2017. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Cutler Group reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 195 Zimmer Biomet shares in Q2 2023, an estimated $25K.
  • Cutler Group first reported a position in Zimmer Biomet in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Zimmer Biomet position peaked at $4.51M in Q3 2017.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.